Page last updated: 2024-08-21

pyrazines and Cirrhoses, Experimental Liver

pyrazines has been researched along with Cirrhoses, Experimental Liver in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's5 (55.56)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, X; Chung, RT; Fuchs, BC; He, L; Holmes, JA; Hong, J; Hu, Q; Jiang, Y; Jin, Q; Li, S; Li, W; Liao, Y; Lidofsky, A; Lin, W; Lin, Z; Liu, Y; Qu, C; Tu, M; Wei, L; Yuan, H; Zheng, D1
Aihara, Y; Douhara, A; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Moriya, K; Namisaki, T; Noguchi, R; Shirai, Y; Yanase, K; Yoshii, J; Yoshiji, H1
Ahn, CY; Bae, SH; Bae, SK; Jung, YS; Kim, T; Kim, YC; Lee, MG; Shin, WG1
Bae, SK; Cho, MK; Kang, KW; Kim, CW; Kim, SG; Kim, YG; Lee, MG1
Bae, SK; Kim, SG; Lee, I; Lee, JY; Lee, MG; Lee, SJ; Lee, Y1
Li, XS; Liu, LY; Liu, ZQ; Tan, LX1
Chang, FC; Chen, KJ; Hong, CY; Huang, YT1
Chang, FC; Chen, KJ; Hong, CY; Huang, YT; Lin, JG1
Choi, SH; Ha, JR; Kang, KW; Kim, CW; Kim, SG1

Other Studies

9 other study(ies) available for pyrazines and Cirrhoses, Experimental Liver

ArticleYear
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
    Hepatology (Baltimore, Md.), 2018, Volume: 68, Issue:3

    Topics: Animals; Drug Evaluation, Preclinical; Hep G2 Cells; Hepatic Stellate Cells; Hepatocytes; Humans; Indazoles; Liver Cirrhosis, Experimental; Male; Mice, Inbred C57BL; Pyrazines; Rats; Syk Kinase

2018
Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.
    Journal of gastroenterology, 2014, Volume: 49, Issue:3

    Topics: Animals; Becaplermin; Cell Proliferation; Collagen; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Gene Expression Regulation; Hepatic Stellate Cells; Liver Cirrhosis, Experimental; Male; Phosphorylation; Proto-Oncogene Proteins c-sis; Pyrazines; Rats; Rats, Inbred F344; Sitagliptin Phosphate; Swine; Transforming Growth Factor beta1; Triazoles

2014
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
    British journal of pharmacology, 2009, Volume: 156, Issue:6

    Topics: Animals; Area Under Curve; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Liver; Liver Cirrhosis, Experimental; Pyrazines; Rats; Schistosomicides; Thiones; Thiophenes

2009
Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:14

    Topics: Animals; CCAAT-Enhancer-Binding Proteins; Extracellular Matrix; Liver; Liver Cirrhosis, Experimental; Liver Regeneration; Models, Biological; Pyrazines; Rats; RNA, Messenger; Survival Analysis; Thiones; Thiophenes; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
    International journal of pharmaceutics, 2004, May-04, Volume: 275, Issue:1-2

    Topics: Administration, Oral; Animals; Area Under Curve; Blood Proteins; Dimethylnitrosamine; Injections, Intravenous; Liver Cirrhosis, Experimental; Male; Microsomes, Liver; Protein Binding; Pyrazines; Rats; Rats, Sprague-Dawley; Schistosomicides; Thiones; Thiophenes; Time Factors; Tissue Distribution

2004
[Effects of combination therapy of rehin and tetramethylpyrazine on experimental hepatic fibrosis induced by tetrachloride].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2004, Volume: 12, Issue:11

    Topics: Animals; Anthraquinones; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Drug Therapy, Combination; Liver Cirrhosis, Experimental; Male; Pyrazines; Rats; Rats, Wistar

2004
Acute hemodynamic effects of tetramethylpyrazine and tetrandrine on cirrhotic rats.
    Planta medica, 1999, Volume: 65, Issue:2

    Topics: Alkaloids; Animals; Antihypertensive Agents; Benzylisoquinolines; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Pyrazines; Rats; Rats, Sprague-Dawley

1999
Haemodynamic effects of chronic tetramethylpyrazine administration on portal hypertensive rats.
    European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:9

    Topics: Animals; Female; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Portal Pressure; Portal Vein; Pyrazines; Rats; Vasodilator Agents

1999
Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression.
    Chemico-biological interactions, 2002, Jan-22, Volume: 139, Issue:1

    Topics: Animals; Base Sequence; Dimethylnitrosamine; DNA Primers; Glyceraldehyde-3-Phosphate Dehydrogenases; Liver Cirrhosis, Experimental; Pyrazines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiones; Thiophenes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2002